The potential of immune biomarkers to advance personalized medicine approaches for schizophrenia.

J Nerv Ment Dis. 2015 May;203(5):393-9. Cox D, Chan MK, Bahn S.   Molecular profiling studies have helped increase the understanding of the immune processes thought to be involved in the etiology and pathophysiology of psychiatric disorders such as schizophrenia. Current therapeutic interventions with first- and second-generation antipsychotics are suboptimal. Poor response rates and debilitating(…)